Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
21
CYTK Quote, Financials, Valuation and Earnings
Last price:
$42.91
Seasonality move
:
1.46%
Day range:
$42.86 - $44.68
52-week range:
$40.53 - $75.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
261.78x
P/B ratio:
61.87x
Volume:
1.3M
Avg. volume:
1.9M
1-year change:
-32.11%
Market cap:
$5.1B
Revenue:
$18.5M
EPS (TTM):
-$5.26
CYTK Analysts' Consensus Rating
The 13 analysts providing 12-month price projections for Cytokinetics shares anticipate an average target of $78.40, ranging from a low estimate of $47.00 to a high estimate of $120.00. This average target implies a growth of 81.15% compared to the current stock price of $43.28.
Consensus Price Target
$78.40
Highest Price Target
$120.00
Lowest Price Target
$47.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 7 | 10 | 10 |
| Hold | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
CYTK Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 9.23% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 6.65% over the past day.
Buy
93
ESLT alert for Mar 19
Elbit Systems [ESLT] is up 0.6% over the past day.
